Ameriprise Financial Inc Amarin Corp Plcuk Transaction History

Ameriprise Financial Inc

  • $381 Billion
  • Q3 2024

A detailed history of Ameriprise Financial Inc transactions in Amarin Corp Plcuk stock. As of the latest transaction made, Ameriprise Financial Inc holds 276,219 shares of AMRN stock, worth $121,536. This represents 0.0% of its overall portfolio holdings.

Number of Shares
276,219
Previous 276,319 0.04%
Holding current value
$121,536
Previous $190,000 8.42%
% of portfolio
0.0%
Previous 0.0%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$0.57 - $0.8 $56 - $80
-100 Reduced 0.04%
276,219 $174,000
Q2 2024

Aug 14, 2024
SELL
$0.63 - $1.07 $563,845 - $957,642
-894,993 Reduced 76.41%
276,319 $190,000
Q1 2024

May 15, 2024
SELL
$0.82 - $1.35 $50,320 - $82,844
-61,366 Reduced 4.98%
1,171,312 $1.04 Million
Q4 2023

Feb 14, 2024
SELL
$0.66 - $0.91 $53,386 - $73,608
-80,889 Reduced 6.16%
1,232,678 $1.07 Million
Q3 2023

Nov 14, 2023
SELL
$0.85 - $1.43 $10,477 - $17,627
-12,327 Reduced 0.93%
1,313,567 $1.21 Million
Q2 2023

Aug 14, 2023
BUY
$1.12 - $1.49 $20,341 - $27,061
18,162 Added 1.39%
1,325,894 $1.58 Million
Q1 2023

May 15, 2023
BUY
$1.19 - $2.19 $36,414 - $67,014
30,600 Added 2.4%
1,307,732 $1.96 Million
Q4 2022

Feb 14, 2023
SELL
$1.07 - $1.34 $49,783 - $62,346
-46,527 Reduced 3.52%
1,277,132 $1.55 Million
Q3 2022

Nov 14, 2022
SELL
$1.09 - $1.67 $11,608 - $17,785
-10,650 Reduced 0.8%
1,323,659 $1.44 Million
Q2 2022

Aug 15, 2022
BUY
$1.13 - $3.69 $60,158 - $196,448
53,238 Added 4.16%
1,334,309 $1.99 Million
Q1 2022

May 16, 2022
BUY
$2.85 - $3.73 $42,165 - $55,185
14,795 Added 1.17%
1,281,071 $4.21 Million
Q4 2021

Feb 14, 2022
SELL
$3.24 - $5.18 $16,993 - $27,169
-5,245 Reduced 0.41%
1,266,276 $4.27 Million
Q3 2021

Nov 15, 2021
BUY
$3.94 - $5.84 $45,526 - $67,481
11,555 Added 0.92%
1,271,521 $6.49 Million
Q2 2021

Aug 16, 2021
SELL
$4.26 - $6.5 $1.29 Million - $1.97 Million
-303,766 Reduced 19.43%
1,259,966 $5.52 Million
Q1 2021

May 17, 2021
BUY
$5.03 - $8.8 $685,211 - $1.2 Million
136,225 Added 9.54%
1,563,732 $9.71 Million
Q4 2020

Feb 12, 2021
SELL
$4.04 - $5.31 $88,532 - $116,363
-21,914 Reduced 1.51%
1,427,507 $6.98 Million
Q3 2020

Nov 16, 2020
BUY
$3.64 - $7.76 $1.53 Million - $3.26 Million
419,783 Added 40.77%
1,449,421 $6.09 Million
Q2 2020

Aug 14, 2020
BUY
$4.78 - $8.26 $126,144 - $217,981
26,390 Added 2.63%
1,029,638 $7.12 Million
Q1 2020

May 15, 2020
BUY
$4.0 - $21.53 $1.63 Million - $8.79 Million
408,330 Added 68.64%
1,003,248 $2.51 Million
Q4 2019

Feb 14, 2020
SELL
$13.94 - $24.12 $50,476 - $87,338
-3,621 Reduced 0.6%
594,918 $12.8 Million
Q3 2019

Nov 14, 2019
BUY
$13.89 - $23.16 $371,113 - $618,788
26,718 Added 4.67%
598,539 $9.08 Million
Q2 2019

Aug 14, 2019
BUY
$16.27 - $20.51 $3.58 Million - $4.52 Million
220,244 Added 62.64%
571,821 $11.1 Million
Q1 2019

May 15, 2019
BUY
$12.61 - $22.33 $207,850 - $368,065
16,483 Added 4.92%
351,577 $7.3 Million
Q4 2018

Feb 14, 2019
SELL
$12.41 - $22.98 $444,364 - $822,844
-35,807 Reduced 9.65%
335,094 $4.56 Million
Q3 2018

Nov 14, 2018
SELL
$2.45 - $16.27 $775,437 - $5.15 Million
-316,505 Reduced 46.04%
370,901 $6.04 Million
Q2 2018

Aug 14, 2018
BUY
$2.68 - $3.48 $710,931 - $923,150
265,273 Added 62.84%
687,406 $2.09 Million
Q1 2018

May 15, 2018
BUY
$2.99 - $4.44 $60,368 - $89,643
20,190 Added 5.02%
422,133 $1.27 Million
Q4 2017

Feb 12, 2018
BUY
$3.06 - $4.09 $80,979 - $108,237
26,464 Added 7.05%
401,943 $1.61 Million
Q3 2017

Nov 07, 2017
BUY
$3.03 - $3.72 $1.14 Million - $1.4 Million
375,479
375,479 $1.31 Million

Others Institutions Holding AMRN

# of Institutions
177
Shares Held
65.1M
Call Options Held
258K
Put Options Held
98K
View Full List

About AMARIN CORP PLCUK

AMRN Quotes by TradingView
  • Ticker AMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 403,206,016
  • Market Cap $177M
  • Description
  • Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...
More about AMRN
Track This Portfolio

Track Ameriprise Financial Inc Portfolio

Follow Ameriprise Financial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email